{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:08:13Z","timestamp":1774566493535,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"DOI":"10.7759\/cureus.102427","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:39:18Z","timestamp":1769553558000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefdinir-Associated Myopericarditis"],"prefix":"10.7759","author":[{"given":"Chirag","family":"Lodha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Casals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krunal","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Van Name","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afrin","family":"Naz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27631-8","article-title":"Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database","volume":"13","author":"Nguyen LS","year":"2022","unstructured":"Nguyen LS, Cooper LT, Kerneis M, et al.. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022, 13:25. 10.1038\/s41467-021-27631-8","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60870-2","article-title":"Myocarditis related to drug hypersensitivity","volume":"60","author":"Taliercio C","year":"1985","unstructured":"Taliercio C, Olney B, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985, 60:463-8. 10.1016\/S0025-6196(12)60870-2","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-006-1430-0","article-title":"Fatal cephalosporin-induced acute hypersensitivity myocarditis","volume":"27","author":"Chikwava KR","year":"2006","unstructured":"Chikwava KR, Savell VH Jr, Boyd TK. Fatal cephalosporin-induced acute hypersensitivity myocarditis. Pediatr Cardiol. 2006, 27:777-80. 10.1007\/s00246-006-1430-0","journal-title":"Pediatr Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(98)70509-8","article-title":"Hypersensitivity myocarditis caused by an allergic reaction to cefaclor","volume":"132","author":"Beghetti M","year":"1998","unstructured":"Beghetti M, Wilson GJ, Bohn D, Benson L. Hypersensitivity myocarditis caused by an allergic reaction to cefaclor. J Pediatr. 1998, 132:172-3.","journal-title":"J Pediatr"},{"key":"ref5","article-title":"Myocarditis: causes and pathogenesis","author":"Cooper L","year":"2025","unstructured":"Cooper L. Myocarditis: causes and pathogenesis. UpToDate. McKenna W, Yeon S (ed): UpToDate, 2025."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti M","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017, 70:2363-75. 10.1016\/j.jacc.2017.09.023","journal-title":"J Am Coll Cardiol"},{"key":"ref7","article-title":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury","year":"2012","unstructured":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464130-00004","article-title":"Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections","volume":"64","author":"Perry CM","year":"2004","unstructured":"Perry CM, Scott LJ. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections. Drugs. 2004, 64:1433-64. 10.2165\/00003495-200464130-00004","journal-title":"Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439053-cefdinir-associated-myopericarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:39:19Z","timestamp":1769553559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439053-cefdinir-associated-myopericarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.102427","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}